Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.55 |
| ▸ | MAPT | P10636 | 3/20 | 0.55 |
| ▸ | MEN1 | O00255 | 3/20 | 0.55 |
| ▸ | HPGD | P15428 | 1/20 | 0.55 |
| ▸ | CCR6 | P51684 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 3/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.51 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.51 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4033959 | 0.81 | MAPT (0.66) | L3MBTL1ALDH1A1KMT2AMAPTMEN1 | |
| SCHEMBL6795704 | 0.81 | MAPT (0.52) | ALDH1A1KMT2AMAPTMEN1HPGD | |
| SCHEMBL6433592 | 0.80 | KMT2A (0.65) | L3MBTL1ALDH1A1KMT2AMAPTMEN1 | |
| SCHEMBL4844382 | 0.79 | ALDH1A1 (0.70) | ALDH1A1KMT2AMAPTMEN1PKM | |
| SCHEMBL14192526 | 0.77 | ALDH1A1 (0.73) | L3MBTL1ALDH1A1KMT2AMAPTMEN1 | |
| SCHEMBL30168150 | 0.76 | ALDH1A1 (0.67) | L3MBTL1ALDH1A1KMT2AMAPTMEN1 | |
| SCHEMBL14202810 | 0.76 | ALDH1A1 (0.67) | L3MBTL1ALDH1A1KMT2AMAPTMEN1 | |
| SCHEMBL10674588 | 0.76 | ALDH1A1 (0.67) | L3MBTL1ALDH1A1KMT2AMAPTMEN1 | |
| SCHEMBL2071340 | 0.75 | L3MBTL1 (0.81) | L3MBTL1ALDH1A1KMT2AMAPTMEN1 | |
| SCHEMBL29106604 | 0.74 | MAPT (0.66) | L3MBTL1ALDH1A1KMT2AMAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040058903-A1 | Benzamide compounds as apo b secretion inhibitors | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-03-25 | — | — | US | disclosed |
| CN-1478077-A | Benzamide compounds as APO B secretion inhibitors | ����ҩƷ��ҵ��ʽ���� | 2004-02-25 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040058903-A1 | Benzamide compounds as apo b secretion inhibitors | APOB, APOL1, SCARB1 | L3MBTL1 1793/4885ALDH1A1 1427/4885KMT2A 2457/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.